Form 4: Johnson & Johnson Executive Reports Stock Transactions
SEC Form 4 Filing
Robert J. Decker, VP Corporate Controller at Johnson & Johnson, reports transactions involving company stock, including acquisitions and disposals related to vesting of restricted and performance share units.
Summary
- Robert J. Decker, VP Corporate Controller of Johnson & Johnson, filed a Form 4 detailing changes in beneficial ownership of JNJ stock.
- The reported transactions include the acquisition of common stock through the vesting of Restricted Share Units (RSUs) and Performance Share Units (PSUs) awarded under the company's Long-Term Incentive Plan.
- Shares were also disposed of to cover tax obligations upon the vesting of RSUs and PSUs.
- As of February 18, 2025, Decker directly owns 20,022 shares of JNJ common stock.
- Decker also indirectly owns 620 shares through a 401k and 134 shares through an ESOP.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions by an executive, and does not inherently convey positive or negative sentiment. It's a neutral disclosure required for transparency.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.
Comparison to Industry Standards
- Executive compensation packages often include stock options, restricted stock units (RSUs), and performance share units (PSUs) to align management's interests with those of shareholders.
- The vesting schedules and terms of these equity grants are typically detailed in proxy statements and other SEC filings.
- Companies like Pfizer (PFE) and Merck (MRK) also utilize similar long-term incentive plans for their executives.
Stakeholder Impact
- The filing provides transparency to shareholders regarding executive stock ownership.
- The transactions themselves have a minimal direct impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 2022/02/14 | Date of grant for some of the Restricted Share Units and Performance Share Units. |
| 2023/02/13 | Date of grant for some of the Restricted Share Units. |
| 2024/02/15 | Date of grant for some of the Restricted Share Units. |
| 2025/01/31 | Most recent reporting date for shares held by ESOP and accrued due to dividend reinvestment. |
| 2025/02/13 | Transaction date for the conversion of 312 Restricted Share Units to common stock. |
| 2025/02/14 | Transaction date for the conversion of 850 Restricted Share Units and 1,351 Performance Share Units to common stock; also, shares withheld for payment of taxes. |
| 2025/02/15 | Transaction date for the conversion of 339 Restricted Share Units to common stock. |
| 2025/02/18 | Date of Form 4 signature. |
Keywords
Form 4, Beneficial Ownership, Stock Transactions, Restricted Share Units, Performance Share Units, Long-Term Incentive Plan, Johnson & Johnson, JNJ, Decker, Vesting
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.